Literature DB >> 17071733

Adrenomedullin inhibits angiotensin II-induced oxidative stress via Csk-mediated inhibition of Src activity.

Jing Liu1, Tatsuo Shimosawa, Hiromitsu Matsui, Fanyin Meng, Scott C Supowit, Donald J DiPette, Katsuyuki Ando, Toshiro Fujita.   

Abstract

We have demonstrated that adrenomedullin (AM) protects against angiotensin II (ANG II)-induced cardiovascular damage through the attenuation of increased oxidative stress observed in AM-deficient mice. However, the mechanism(s) that underlie this activity remain unclear. To address this question, we investigated the effect of AM on ANG II-stimulated reactive oxygen species (ROS) production in cultured rat aortic vascular smooth muscle cells (VSMCs). ANG II markedly increased ROS production through activation of NADPH oxidase. This effect was significantly attenuated by AM in a concentration-dependent manner. This effect was mimicked by dibutyl-cAMP and blocked by pretreatment with N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide hydrochloride (H-89), a protein kinase A inhibitor, and CGRP(8-37), an AM/CGRP receptor antagonist. This inhibitory effect of AM was also lost following the expression of a constitutively active Src. Moreover, AM intersected ANG II signaling by inducing COOH-terminal Src kinase (Csk) activation that, in turn, inhibits Src activation. These data, for the first time, demonstrate that AM attenuates the ANG II-induced increase in ROS in VSMCs via activation of Csk, thereby inhibiting Src activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17071733     DOI: 10.1152/ajpheart.00486.2006

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  9 in total

Review 1.  Protecting against vascular disease in brain.

Authors:  Frank M Faraci
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-02-18       Impact factor: 4.733

Review 2.  Oxidative stress and organ damages.

Authors:  Sayoko Ogura; Tatsuo Shimosawa
Journal:  Curr Hypertens Rep       Date:  2014-08       Impact factor: 5.369

3.  Oral Resolvin D1 attenuates early inflammation but not intimal hyperplasia in a rat carotid angioplasty model.

Authors:  Giorgio Mottola; Evan C Werlin; Bian Wu; Mian Chen; Anuran Chatterjee; Melinda S Schaller; Michael S Conte
Journal:  Prostaglandins Other Lipid Mediat       Date:  2019-12-10       Impact factor: 3.072

4.  Receptor activity-modifying protein-1 augments cerebrovascular responses to calcitonin gene-related peptide and inhibits angiotensin II-induced vascular dysfunction.

Authors:  Sophocles Chrissobolis; Zhongming Zhang; Dale A Kinzenbaw; Cynthia M Lynch; Andrew F Russo; Frank M Faraci
Journal:  Stroke       Date:  2010-09-02       Impact factor: 7.914

Review 5.  Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Authors:  Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

6.  Attenuation of hyperoxia-induced lung injury in rats by adrenomedullin.

Authors:  Wei Tao; Yu-Sheng Shu; Qian-Bing Miao; Ya-Bing Zhu
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

7.  Calcitonin gene-related peptide inhibits angiotensin II-induced NADPH oxidase-dependent ROS via the Src/STAT3 signalling pathway.

Authors:  Hong-Min Luo; Xia Wu; Xian Xian; Lu-Yao Wang; Liang-Yu Zhu; Hong-Yu Sun; Lei Yang; Wen-Xuan Liu
Journal:  J Cell Mol Med       Date:  2020-05-05       Impact factor: 5.310

Review 8.  The role of A-kinase anchoring proteins in cardiac oxidative stress.

Authors:  Dario Diviani; Halima Osman; Marion Delaunay; Simon Kaiser
Journal:  Biochem Soc Trans       Date:  2019-10-31       Impact factor: 5.407

Review 9.  Uremic Toxins and Vascular Calcification-Missing the Forest for All the Trees.

Authors:  Nikolas Rapp; Pieter Evenepoel; Peter Stenvinkel; Leon Schurgers
Journal:  Toxins (Basel)       Date:  2020-09-29       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.